跳至主要内容
临床试验/CTRI/2025/12/098846
CTRI/2025/12/098846尚未招募不适用

Evaluating the concordance between AI-based Large Language Model recommendations and Virtual Molecular Tumor Board expert consensus for solid tumor cases in India

未提供1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年12月21日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1

研究概览

简要总结

This prospective, blinded, cross-sectional study evaluates the concordance between treatment recommendations generated by large language model (LLM)–based decision-support tools and expert consensus from the Tamil Nadu Medical and Pediatric Oncologist Society (TAMPOS) Virtual Molecular Tumor Board (vMTB) for precision oncology cases in India. Consecutive de-identified solid tumor cases discussed at vMTB sessions (September–December 2025) will be analyzed. AI tools will undergo extraction validation, reproducibility testing (two-run protocol with escalation to a third run if inconsistent), and blinded concordance scoring across pathway, therapy, and evidence level dimensions. The primary hypothesis is that LLM systems will meet predefined concordance thresholds (~90% for high-evidence and ~40% for low-evidence recommendations), consistent with international benchmarking studies (Sunami et al., 2024).

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Age 18.00 to 80.00 years.
  • The subject should have solid tumors.

排除标准

  • 未提供

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr S Arun Seshachalam

Dr GVN Cancer Institute GVN Riverside Hospital Tiruchirappalli Tamil Nadu

研究点 (1)

Loading locations...

相似试验

The role of Artificial Intelligence in Cancer... | 临床试验